» Articles » PMID: 35204690

Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Feb 25
PMID 35204690
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of our review is to briefly show what different compounds of marine origin, from low molecular weight ones to peptides and proteins, offer for understanding the structure and mechanism of action of nicotinic acetylcholine receptors (nAChRs) and for finding novel drugs to combat the diseases where nAChRs may be involved. The importance of the mentioned classes of ligands has changed with time; a protein from the marine snake venom was the first excellent tool to characterize the muscle-type nAChRs from the electric ray, while at present, muscle and α7 receptors are labeled with the radioactive or fluorescent derivatives prepared from α-bungarotoxin isolated from the many-banded krait. The most sophisticated instruments to distinguish muscle from neuronal nAChRs, and especially distinct subtypes within the latter, are α-conotoxins. Such information is crucial for fundamental studies on the nAChR revealing the properties of their orthosteric and allosteric binding sites and mechanisms of the channel opening and closure. Similar data are provided by low-molecular weight compounds of marine origin, but here the main purpose is drug design. In our review we tried to show what has been obtained in the last decade when the listed classes of compounds were used in the nAChR research, applying computer modeling, synthetic analogues and receptor mutants, X-ray and electron-microscopy analyses of complexes with the nAChRs, and their models which are acetylcholine-binding proteins and heterologously-expressed ligand-binding domains.

Citing Articles

Role of Glial Cells and Receptors in Schizophrenia Pathogenesis.

Tizabi Y, Antonelli M, Tizabi D, Aschner M Neurochem Res. 2025; 50(2):85.

PMID: 39869278 DOI: 10.1007/s11064-025-04336-8.


Chemical Synthesis and Insecticidal Activity Research Based on α-Conotoxins.

Lin C, Qin H, Liao Y, Chen J, Gao B Molecules. 2024; 29(12).

PMID: 38930912 PMC: 11206848. DOI: 10.3390/molecules29122846.


The Cyclic Imine Core Common to the Marine Macrocyclic Toxins Is Sufficient to Dictate Nicotinic Acetylcholine Receptor Antagonism.

Bourne Y, Sulzenbacher G, Chabaud L, Araoz R, Radic Z, Conrod S Mar Drugs. 2024; 22(4).

PMID: 38667766 PMC: 11050823. DOI: 10.3390/md22040149.


Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease.

Soares E, Costa A, Ferrolho G, Ureshino R, Getachew B, Costa S Cells. 2024; 13(6.

PMID: 38534318 PMC: 10969434. DOI: 10.3390/cells13060474.


Fifty Years of Animal Toxin Research at the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS.

Tsetlin V, Shelukhina I, Kozlov S, Kasheverov I Int J Mol Sci. 2023; 24(18).

PMID: 37762187 PMC: 10530976. DOI: 10.3390/ijms241813884.


References
1.
Napier I, Klimis H, Rycroft B, Jin A, Alewood P, Motin L . Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain. Neuropharmacology. 2012; 62(7):2202-7. DOI: 10.1016/j.neuropharm.2012.01.016. View

2.
Abraham N, Healy M, Ragnarsson L, Brust A, Alewood P, Lewis R . Structural mechanisms for α-conotoxin activity at the human α3β4 nicotinic acetylcholine receptor. Sci Rep. 2017; 7:45466. PMC: 5374441. DOI: 10.1038/srep45466. View

3.
Hernandez-Samano A, Falcon A, Zamudio F, Ortiz-Arellano M, Lopez-Vera E, Aguilar M . A turripeptide from Polystira nobilis venom inhibits human α3β2 and α7 nicotinic acetylcholine receptors. Insect Biochem Mol Biol. 2020; 124:103416. DOI: 10.1016/j.ibmb.2020.103416. View

4.
Chen J, Liang L, Ning H, Cai F, Liu Z, Zhang L . Cloning, Synthesis and Functional Characterization of a Novel α-Conotoxin Lt1.3. Mar Drugs. 2018; 16(4). PMC: 5923399. DOI: 10.3390/md16040112. View

5.
Yu R, Kompella S, Adams D, Craik D, Kaas Q . Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor. J Med Chem. 2013; 56(9):3557-67. DOI: 10.1021/jm400041h. View